96 related articles for article (PubMed ID: 3485689)
1. Inactivation of C3a by a monocarboxypeptidase present in culture supernatants of stimulated guinea pig peritoneal macrophages.
Kreuzpaintner G; Damerau B; Zimmermann B; Plummer TH; Brade V
J Immunol; 1986 May; 136(9):3384-9. PubMed ID: 3485689
[TBL] [Abstract][Full Text] [Related]
2. Induction of thromboxane release from macrophages by anaphylatoxic peptide C3a of complement and synthetic hexapeptide C3a 72-77.
Hartung HP; Bitter-Suermann D; Hadding U
J Immunol; 1983 Mar; 130(3):1345-9. PubMed ID: 6600482
[TBL] [Abstract][Full Text] [Related]
3. The anaphylatoxic peptide C3a of guinea pig complement. I. Purification, physicochemical and antigenetic properties.
Meuer S; Becker S; Hadding U; Bitter-Suermann D
Z Immunitatsforsch Immunobiol; 1978 Mar; 154(2):135-46. PubMed ID: 77089
[TBL] [Abstract][Full Text] [Related]
4. Effect of cycloheximide and of anti-C3 Fab' on the intrinsic synthesis and secretion of lysosomal enzyme and of complement components by guinea-pig peritoneal macrophages.
Kreuzpaintner G; Brade V
Immunology; 1983 Jun; 49(2):337-42. PubMed ID: 6552217
[TBL] [Abstract][Full Text] [Related]
5. C3a(C3adesArg) induces production and release of interleukin 1 by cultured human monocytes.
Haeffner-Cavaillon N; Cavaillon JM; Laude M; Kazatchkine MD
J Immunol; 1987 Aug; 139(3):794-9. PubMed ID: 3496391
[TBL] [Abstract][Full Text] [Related]
6. Role of histamine in the spasmogenic effect of the complement peptides C3a and C5a-desArg (classical anaphylatoxin).
Sorgenfrei J; Damerau B; Vogt W
Agents Actions; 1982 Apr; 12(1-2):118-21. PubMed ID: 6177210
[TBL] [Abstract][Full Text] [Related]
7. C3 activation by a new factor B-dependent enzyme detected in culture supernatant from guinea-pig peritoneal macrophages.
Beuscher HU; Brade V
Immunology; 1986 Aug; 58(4):545-51. PubMed ID: 3089917
[TBL] [Abstract][Full Text] [Related]
8. Contraction of guinea pig lung by synthetic oligopeptides related to human C3a.
Huey R; Erickson BW; Bloor CM; Hugli TE
Immunopharmacology; 1984 Aug; 8(1):37-45. PubMed ID: 6333413
[TBL] [Abstract][Full Text] [Related]
9. Quantitative studies of the secretion of complement component C3 by resident, elicited and activated macrophages. Comparison with C2, C4 and lysosomal enzyme release.
Zimmer B; Hartung HP; Scharfenberger G; Bitter-Suermann D; Hadding U
Eur J Immunol; 1982 May; 12(5):426-30. PubMed ID: 7094993
[TBL] [Abstract][Full Text] [Related]
10. An inherited deficiency of the third component of complement, C3, in guinea pigs.
Burger R; Gordon J; Stevenson G; Ramadori G; Zanker B; Hadding U; Bitter-Suermann D
Eur J Immunol; 1986 Jan; 16(1):7-11. PubMed ID: 3512275
[TBL] [Abstract][Full Text] [Related]
11. Effects of activated complement components on enzyme secretion by macrophages.
Schorlemmer HU; Allison AC
Immunology; 1976 Nov; 31(5):781-8. PubMed ID: 992710
[TBL] [Abstract][Full Text] [Related]
12. Factor C3f is a spasmogenic fragment released from C3b by factors I and H: the heptadeca-peptide C3f was synthesized and characterized.
Ganu VS; Müller-Eberhard HJ; Hugli TE
Mol Immunol; 1989 Oct; 26(10):939-48. PubMed ID: 2531841
[TBL] [Abstract][Full Text] [Related]
13. Functional analysis and quantification of the complement C3 derived anaphylatoxin C3a with a monoclonal antibody.
Burger R; Bader A; Kirschfink M; Rother U; Schrod L; Wörner I; Zilow G
Clin Exp Immunol; 1987 Jun; 68(3):703-11. PubMed ID: 3498585
[TBL] [Abstract][Full Text] [Related]
14. Generation of anaphylatoxin activity related to C3a, by treatment of human serum with the nitrogen nucleophile N2H4 or the chaotrope KSCN.
von Zabern I; Damerau B; Nolte R; Grünefeld E; Vogt W
Scand J Immunol; 1985 Dec; 22(6):639-51. PubMed ID: 3937227
[TBL] [Abstract][Full Text] [Related]
15. Degradation of human anaphylatoxin C3a by rat peritoneal mast cells: a role for the secretory granule enzyme chymase and heparin proteoglycan.
Gervasoni JE; Conrad DH; Hugli TE; Schwartz LB; Ruddy S
J Immunol; 1986 Jan; 136(1):285-92. PubMed ID: 3510005
[TBL] [Abstract][Full Text] [Related]
16. Potentiation of the anaphylatoxins in vivo using an inhibitor of serum carboxypeptidase N (SCPN). I. Lethality and pathologic effects on pulmonary tissue.
Huey R; Bloor CM; Kawahara MS; Hugli TE
Am J Pathol; 1983 Jul; 112(1):48-60. PubMed ID: 6859228
[TBL] [Abstract][Full Text] [Related]
17. Complement regulation in murine and human hypercholesterolemia and role in the control of macrophage and smooth muscle cell proliferation.
Verdeguer F; Castro C; Kubicek M; Pla D; Vila-Caballer M; Vinué A; Civeira F; Pocoví M; Calvete JJ; Andrés V
Cardiovasc Res; 2007 Nov; 76(2):340-50. PubMed ID: 17673191
[TBL] [Abstract][Full Text] [Related]
18. Production of the complement cleavage product, C3a, by activated macrophages and its tumorolytic effects.
Ferluga J; Schorlemmer HU; Baptista LC; Allison AC
Clin Exp Immunol; 1978 Mar; 31(3):512-7. PubMed ID: 657590
[TBL] [Abstract][Full Text] [Related]
19. Activation of the third complement component (C3) and C3a generation in cardiac anaphylaxis: histamine release and associated inotropic and chronotropic effects.
del Balzo U; Polley MJ; Levi R
J Pharmacol Exp Ther; 1988 Sep; 246(3):911-6. PubMed ID: 2458450
[TBL] [Abstract][Full Text] [Related]
20. Macrophage secretion and the complement cleavage product C3a in the pathogenesis of infections by mycoplasmas and L-forms of bacteria and in immunity to these organisms.
Taylor-Robinson D; Schorlemmer HU; Furr PM; Allison AC
Clin Exp Immunol; 1978 Sep; 33(3):486-94. PubMed ID: 367651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
